Assam: Banned Tablets, Cough Syrup Seized In Nagaon, 2 Arrested

Nagaon : Police apprehended two persons and recovered a large quantity of drugs from a vehicle in Assam’s Nagaon district on Thursday evening.

The apprehended persons have been identified as Moon Moon Hoque, a lawyer, and Iftikhar Hussain. According to police, based on secret information, a search operation was conducted in the Morikolong area in the district and 5,871 prohibited tablets and 190 cough syrup bottles were recovered from a vehicle.

Rupjyoti Kalita, Additional Superintendent of Police of Nagaon district said, “The operation was launched on Thursday evening and we recovered 5,871 prohibited tablets and 190 cough syrup bottles from a vehicle in the Morikolong area.”

“We have also apprehended two persons while they were trying to transport the contraband drugs. Our investigation is on,” Kalita added.

A few days ago, the Assam police seized a huge quantity of contraband drugs from a Tripura-bound truck and apprehended the driver in the Karimganj district.

The police said that the driver identified as Mukesh Yadav was apprehended along the Assam-Tripura border on Monday.

They recovered eight cartoons containing 1280 bottles of cough syrup bottles whose market value is estimated at around Rs 6.50 lakh.

“Acting on a tip-off, the police of the Churaibari watch post along the Assam-Tripura border on Sunday intercepted a truck during checking, the police team recovered 1280 bottles of cough syrup from the truck,” In-Charge of the Churaibari police watch post-Niranjan Das told ANI.

According to the police, the truck (container) was coming from Guwahati and was going towards Agartala.

  • Related Posts

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    New Delhi: AstraZeneca’s India-arm has partnered with National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, to build clinical research capabilities at 25 emerging geographies in a bid to extend…

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Following a bumpy regulatory road that involved a refusal-to-file, ImmunityBio has won FDA approval to expand Anktiva into papillary-only non-muscle-invasive bladder cancer (NMIBC). Wednesday’s approval comes nearly three months ahead…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    ‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

    ‘Bone Bonding’ between Mothers and Children, thanks to Meticulous Bone Grafting

    Governments have moved for Price Transparency in Hospitals to help patients cope with bills

    Governments have moved for Price Transparency in Hospitals to help patients cope with bills

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction